Positive detection lateral-flow apparatus and method for small and large analytes

• US 7,517,699 B2
• Filed: 02/21/2006
• Issued: 04/14/2009
• Est. Priority Date: 04/14/2000
• Status: Expired due to Fees

• Current Assignee: Quantrx Biomedical Corporation
• Original Assignee: Quantrx Biomedical Corporation
• Inventors: Wang, Huiying, Buck, Robert L., Bauer, Jeffrey S., Hyatt, Timothy P.
• Primary Examiner(s): Shibuya; Mark L.
• Assistant Examiner(s): Counts; Gary W
• Application Number:
  US11/359,666
• Publication Number:
  US 20060141639A1
• Time in Patent Office: 1,148 Days
• Field of Search: 435/6, 435/7.1, 435 792- 794, 435/287.1, 435/287.7, 435/970, 436/514, 436/518, 436/169, 436/541, 436/808, 422 56- 58, 422/99, 422/101
• US Class Current: 436/518
• CPC Class Codes: G01N 33/54386 Analytical elements
• CPC Class Codes: G01N 33/54388 based on lateral flow
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387
• CPC Class Codes: G01N 33/94 involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
• CPC Class Codes: G01N 33/946 CNS-stimulants, e.g. cocaine, amphetamines

Abstract

Methods and devices for the detection and/or quantification of an analyte in a sample are provided. These are positive detection methods and devices, in that the more analyte is present in the sample, the stronger the signal that is provided. Devices of the invention include a mobilization zone including a mobile or mobilizable detectable analyte analog, a sample application area, primary and secondary capture areas each including an immobilized binding partner having a binding affinity for the analyte being tested for a detectable analyte analog. The mobilization zone, sample application area, primary and secondary capture area are in fluid continuous contact with each other. In these devices, the first immobilized binding partner has an equal or lower apparent affinity for the analyte than it has for the detectable analyte analog. Methods of this invention involve introducing a sample (which is suspected of containing the analyte to be tested for) to a device such as those described herein, and permitting the sample to migrate from the application area to and through the first and secondary binding zones. A detectable tracer conjugate is also permitted to migrate through the device, usually slightly behind the sample so that any analyte in the sample contacts the first binding partner before the conjugate. Results of such methods are read based on the presence and/or intensity of the detectable signal given by conjugate that binds in the second capture area.

Claims

1. A method of making a lateral flow chromatography test strip to determine a presence and/or amount of an analyte in a liquid sample, wherein the test strip comprises:

a mobile or mobilizable detectable tracer area comprising a mobilizable tracer;

a sample application area for applying a liquid sample;

a primary capture area comprising a first binding partner;

a secondary capture area comprising a second binding partner;

wherein the sample application area distally through the detectable tracer area to the primary capture area and then, detectable tracer area, primary capture area and then, detectable tracer area, primary capture area and secondary capture area are in a sequential path of liquid flow along a bibulous substrate that permits separation of components as they flow along the strip, wherein the path of liquid flow extends from the sample application area to the secondary capture area, and the tracer has a physical characteristic that provides specific migration characteristics, that delays arrival of the tracer at the primary capture area relative to the analyte after the liquid sample is placed on the sample application area, such that the tracer reaches the primary capture area after the analyte, and the tracer provides a signal in the secondary capture area that is proportionate to an amount of analyte in the liquid sample,

wherein the method of making the lateral flow chromatography test strip comprises selecting the mobilizable tracer to slow migration of the tracer along the lateral flow chromatography test strip relative to the analyte so that the tracer and analyte separate before the analyte reaches the primary capture area, and selecting the mobilizable tracer comprises selecting the tracer to have a specific physical characteristic that delays arrival of the tracer at the primary capture area relative to the analyte, wherein the specific physical characteristic comprises a polarity, charge or size that interacts with the lateral flow chromatography test strip to delay arrival at the primary capture area.

2. The method of claim 1, wherein the first binding partner comprises a binding partner for the analyte and an analyte analog, and the tracer comprises a labeled analyte that reaches the primary capture area sufficiently after the analyte to allow the analyte to occupy first binding partners of the primary capture area and inhibit binding of the tracer to the first binding partners of the primary capture area, whereby the tracer provides the signal in the secondary capture area that is proportionate to an amount of analyte in the liquid sample.

3. The method of claim 1, wherein the specific physical characteristic of the tracer is that the tracer has a polarity that slows the tracer'"'"'s rate of migration along the lateral flow chromatography test strip to the primary capture area relative to the analyte.

4. The method of claim 1, wherein the specific physical characteristic of the tracer is that the tracer has a charge that slows the tracer'"'"'s rate of migration to the primary capture area along the lateral flow chromatography test strip relative to the analyte.

5. The method of claim 1, wherein the specific physical characteristic of the tracer is that the tracer has a size relative to a pore size of the test strip that slows the tracer'"'"'s rate of migration to the primary capture area relative to the analyte.

6. The method of claim 1, wherein the tracer has a position on the test strip that delays the tracer'"'"'s arrival at the primary capture area relative to the analyte.

7. The method of claim 6, wherein the tracer is located beneath a top surface of the test strip along which the liquid sample flows to the primary capture area.

8. The method of claim 7, wherein the tracer is located beneath the sample application area that extends over the tracer to the top surface of the strip along which the liquid sample flows to the primary capture area.

9. The method of claim 6, wherein the tracer is immobilized in a delayed release location on the test strip that selectively contains a delayed release molecule that delays release of the tracer from the delayed release location as the liquid sample passes through the delayed release location.

10. The method of claim 9, wherein the delayed release molecule comprises one or more of sucrose, mannitol, glycerol, polyvinyl acetate, or polyvinyl pyrrolidone in an effective amount to selectively delay the release of the tracer as the liquid sample migrates through the delayed release location.

11. The method of claim 1, wherein the tracer comprises a conjugate that includes the tracer and a third specific binding partner that specifically binds to the second binding partner.

12. The method of claim 11, wherein the third specific binding partner comprises an analyte or analyte analog, and the second specific binding partner is an antibody that binds the analyte or analog.

13. The method of claim 11, wherein the third specific binding partner comprises an antibody, and the second specific binding partner comprises an antigen or antigen analog.

14. The method of claim 11, wherein the tracer and third specific binding partner are bound by a linker molecule to form the conjugate.

15. The method of claim 14, wherein the linker molecule is a molecule that slows a rate of migration of the conjugate relative to the analyte.

16. The method of claim 14, wherein the tracer comprises a colored particle label.

17. The method of claim 1, wherein the first binding partner comprises binding partners having binding sites that are occupied by the movement of analyte through the primary capture area.